WORSENING OF ANEMIA BY ANGIOTENSIN CONVERTING ENZYME-INHIBITORS AND ITS PREVENTION BY ANTIESTROGENIC STEROID IN CHRONIC-HEMODIALYSIS PATIENTS

被引：46

作者：

ONOYAMA, K

SANAI, T

MOTOMURA, K

FUJISHIMA, M

机构：

来源：

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 1989年 / 13卷

关键词：

D O I：

10.1097/00005344-198900133-00007

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：S27 / S30

页数：4

相关论文

共 23 条

[1] ANAGNOSTOU A, 1976, J LAB CLIN MED, V88, P707
[2] ANAGNOSTOU A, 1986, KIDNEY, P1631
[3] BOURGOIG.JJ, 1968, J LAB CLIN MED, V71, P523
[4] BENEFITS AND RISKS OF PROTRACTED TREATMENT WITH HUMAN RECOMBINANT ERYTHROPOIETIN IN PATIENTS HAVING HEMODIALYSIS
CASATI, S
PASSERINI, P
CAMPISE, MR
GRAZIANI, G
CESANA, B
PERISIC, M
PONTICELLI, C
[J]. BMJ-BRITISH MEDICAL JOURNAL, 1987, 295 (6605): : 1017 - 1020
[5] FISHER JW, 1967, J PHARMACOL EXP THER, V157, P618
[6] FRIED W, 1982, J LAB CLIN MED, V99, P520
[7] GOULD AB, 1973, LAB INVEST, V28, P719
[8] GOULD AB, 1980, J LAB CLIN MED, V96, P523
[9] GRIFFING GT, 1982, LANCET, V1, P1361
[10] HILDEN M, 1968, ACTA MED SCAND, V183, P183